Blackstone Clarus GP L.P.

All filings by Blackstone Clarus GP L.P. on record concern Galera Therapeutics, Inc. Activity is concentrated on a single trading day, 12 November 2019, with 8 filings.

Purchases make up the whole of the open-market record (4 purchases, €2.7M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

In size, the median ticket on the buying side is €726k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 14 November 2019 came the latest disclosure, a transaction in Galera Therapeutics, Inc. The last purchase on record was published on 14 November 2019, which is 2,552 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.